Astex Pharmaceuticals Inc (ASTX.OQ)

ASTX.OQ on NASDAQ Stock Exchange Global Select Market

5.29USD
1 Aug 2013
Price Change (% chg)

$0.06 (+1.15%)
Prev Close
$5.23
Open
$5.35
Day's High
$5.37
Day's Low
$5.29
Volume
14,479
Avg. Vol
--
52-wk High
--
52-wk Low
--

ASTX.OQ

Chart for ASTX.OQ

About

Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. The Company’s two lead... (more)

Overall

Beta: 1.15
Market Cap (Mil.): $494.78
Shares Outstanding (Mil.): 94.60
Dividend: --
Yield (%): --

Financials

  ASTX.OQ Industry Sector
P/E (TTM): 121.37 47.13 37.76
EPS (TTM): 0.04 -- --
ROI: 1.86 -2.58 18.76
ROE: 1.93 -2.66 19.59
Search Stocks

BRIEF-Astex Pharmaceuticals shares up 1 pct after the bell following results

NEW YORK, April 29 - Astex Pharmaceuticals Inc : * Shares were up 1 percent after the bell following the release of its results.

29 Apr 2013

BRIEF-Astex Pharmaceuticals shares up 8.3 pct premarket

NEW YORK, April 3 - Astex Pharmaceuticals Inc : * Shares up 8.3 percent in premarket trading

03 Apr 2013

BRIEF-GIMV sells shares of Astex, Ablynx

BRUSSELS, March 11 - Gimv NV : * Astex stake sale has 0.04 per share positive impact on Gimv * Ablynx stake reduction has 0.07 per share positive impact on Gimv

11 Mar 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Wright Reports
$472.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks